Our findings may facilitate better understanding of NONO-TFE3 tRCC pathogenesis and provide new insight into lncRNA-based diagnosis and treatment of NONO-TFE3 tRCC and other human malignancies. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.